Live data from Hacker News

Open Letter from Gilead CEO: Remdesivir Pricing

stories.gilead.com

1–10 of 114 posts

Re: Open Letter from Gilead CEO: Remdesivir Pricing

#4
> In the U.S., the same government price of $390 per vial will apply. Because of the way the U.S. system is set up and the discounts that government healthcare programs expect, the price for U.S. private insurance companies, will be $520 per vial.

Sigh

How many years of normalizing and internalizing the utter insanity that is the US medical industrial complex does it take to be able to just say that with a straight face?

Re: Open Letter from Gilead CEO: Remdesivir Pricing

#6
post #4

> In the U.S., the same government price of $390 per vial will apply. Because of the way the U.S. system is set up and the discounts that government healthcare programs expect, the price for U.S. private insurance companies, will be $520 per vial. Sigh How many years of normalizing and internalizing the utter insanity that is the US medical industrial complex does it take to be able to just say that with a straight f…

> How many years of normalizing and internalizing the utter insanity that is the US medical industrial complex does it take to be able to just say that with a straight face?

I hate to tell you, but it's not better in Europe just because the racket is obfuscated by several more layers.

Re: Open Letter from Gilead CEO: Remdesivir Pricing

#7
They say the goal is to help as many people as possible, and that this principle has guided their development and pricing of the drug.

How do they reconcile this principle with the huge price difference between the USA and the rest of the world? Or between the developed world and the developing world?

I assume they are still making a profit selling doses at low costs to developing countries. If the goal is to help as many people like they say, why not extend that pricing to everyone?

It’s disappointing that taxpayers fund the development of these drugs and then get screwed by the same companies when it comes time to make a profit.

Re: Open Letter from Gilead CEO: Remdesivir Pricing

#10
post #3

Earlier quoted context omitted.

Very low, but obviously not comparable at all.

Do you have a randomized clinical trial comparing the two treatments?

I’m not certain it matters. The hydroxychloroquine paper was retracted: that’s not a great sign for it’s effectiveness as a treatment.
Post reply on HN